“Trisindoline 5 Compound Inhibits Human Breast Cancer Stem Cell Formation by Downregulating the BCL-2 Gene Expression” (2022) International Journal of Cell and Biomedical Science, 1(2), pp. 65–69. doi:10.59278/cbs.v1i2.19.